Potential Carestream buyers dwindle to two bidders

| | Health Imaging | Economics

It appears there are just two remaining potential bidders vying for control of Carestream Health, according to a Reuters report.

Bain Capital and Thomas H. Lee Partners are the final two firms in the running after others withdrew from the process to acquire Carestream from Onex, according to the report. Once hoping to sell Carestream for $3.5 billion, Onex has now valued the medical imaging company at no more than $2.5 billion, according to Reuters. Read more at the link below:

Bidders for Carestream down to Bain, THL -sources

Related Content

Operations manager, doctors charged in $70M imaging kickback scheme
Positron partners with Upbeat Cardiology Solutions to improve cardiac PET/CT access
‘A huge win’: CMS significantly increases Medicare payments for cardiac CT
A closer look at how FDA's flurpiridaz approval will impact nuclear cardiology
Cath lab techs and nurses see new normal with post-COVID pay
SpectraWAVE raises $50M for FDA-cleared intravascular imaging technology

Around the web

Cardiovascular Business
Cardiology, radiology specialists debate CCTA’s rise as a go-to imaging modality for CAD

CCTA is being utilized more and more for the diagnosis and management of suspected coronary artery disease. An international group of specialists shared their perspective on this ongoing trend.

Cardiovascular Business
New AI program delivers rapid, accurate echo video assessments

The new technology shows early potential to make a significant impact on imaging workflows and patient care. 

Radiology Business
Key Medicare reimbursement and No Surprises Act updates from RSNA 2024

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.